Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vet Clin Pathol ; 49(2): 326-332, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32468599

RESUMO

An adult dog was presented for chronic cough and a recent development of ulcerated, erythematous nares with nasal discharge. Cytology of enlarged peripheral lymph nodes revealed many intracellular and extracellular organisms. These round or rarely oval organisms measured approximately 5-9 µm in diameter and frequently contained several globular structures, ranging from deeply basophilic to magenta. A thin, clear halo was present. Smaller 1-2 µm, magenta forms were also observed. Fungal culture yielded small, wet, raised, irregularly shaped, white to pale tan colonies. Microbiologic staining of cultured material revealed features suggestive of algae. Histopathology of the lymph nodes revealed marked granulomatous inflammation with intralesional algal organisms suggestive of Prototheca. Electron microscopic findings were also consistent with protothecosis. Polymerase chain reaction, followed by direct DNA sequencing, identified the organism as Prototheca wickerhamii. A brief literature review discussing protothecosis in veterinary medicine is included.


Assuntos
Doenças do Cão/diagnóstico por imagem , Infecções/veterinária , Prototheca/isolamento & purificação , Dermatopatias Infecciosas/veterinária , Animais , Biópsia por Agulha Fina/veterinária , Doenças do Cão/patologia , Cães , Infecções/diagnóstico por imagem , Infecções/patologia , Linfonodos/diagnóstico por imagem , Linfonodos/patologia , Masculino , Microscopia Eletrônica/veterinária , Reação em Cadeia da Polimerase/veterinária , Prototheca/genética , Prototheca/ultraestrutura , Análise de Sequência de DNA/veterinária , Dermatopatias Infecciosas/diagnóstico por imagem , Dermatopatias Infecciosas/patologia
2.
J Am Vet Med Assoc ; 245(2): 222-6, 2014 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-24984134

RESUMO

CASE DESCRIPTION: An 8-year-old spayed female Yorkshire Terrier and 5-year-old castrated male West Highland White Terrier were evaluated because of cyclophosphamide intoxication subsequent to pharmacy error. Both dogs received cumulative doses of approximately 1,080 mg of cyclophosphamide/m(2) after cyclophosphamide was erroneously dispensed instead of cyclosporine by different pharmacies. CLINICAL FINDINGS: Both dogs became lethargic, and 1 dog also had anorexia, vomiting, and diarrhea within 2 days after initiation of cyclophosphamide administration. The other dog developed anorexia on the seventh day after initiation of cyclophosphamide administration. The dogs were evaluated by their primary-care veterinarians 9 and 11 days after administration of the first dose of cyclophosphamide, and both had severe leukopenia and thrombocytopenia. TREATMENT AND OUTCOME: One dog was treated on an outpatient basis with broad-spectrum antimicrobials, granulocyte colony-stimulating factor, and an appetite stimulant. The other dog was more severely affected and was hospitalized for 7 days, during which it was treated with broad-spectrum antimicrobials, gastroprotectants, granulocyte colony-stimulating factor, and cryopreserved platelet and packed RBC transfusions. Both dogs fully recovered after treatment. CLINICAL RELEVANCE: This was the first report of survival for dogs with inadvertent prolonged cyclophosphamide intoxication subsequent to pharmacy error. Although the 2 dogs had similar clinical signs and clinicopathologic findings, the severity of disease and treatment required differed for each dog. Dogs can recover from prolonged cyclophosphamide intoxication provided appropriate supportive care is administered.


Assuntos
Antineoplásicos Alquilantes/efeitos adversos , Ciclofosfamida/efeitos adversos , Doenças do Cão/induzido quimicamente , Overdose de Drogas/veterinária , Erros de Medicação/veterinária , Animais , Ciclofosfamida/administração & dosagem , Cães , Feminino , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Substâncias de Crescimento/uso terapêutico , Masculino , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA